Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2000
05/25/2000WO2000029438A1 Egf-like nucleic acids and polypeptides and uses thereof
05/25/2000WO2000029437A1 HYPOXIA-INDUCIBLE FACTOR 1α HIF-1α VARIANTS AND METHODS FOR IDENTIFYING HIF-1α MODULATORS
05/25/2000WO2000029436A1 Protein amsh and cdna thereof
05/25/2000WO2000029435A1 12 human secreted proteins
05/25/2000WO2000029432A1 Heliobacter pylori antigen
05/25/2000WO2000029430A1 Ring finger protein zapop3
05/25/2000WO2000029429A2 Endoplasmic reticulum stress transcription factors atf6 and creb-rp
05/25/2000WO2000029428A2 5t4 tumour-associated antigen for use in tumour immunotherapy
05/25/2000WO2000029427A2 Antennapedia homeodomain helix 3 derived translocation vectors
05/25/2000WO2000029423A1 G protein-coupled receptor resembling the leukotriene b4 receptor
05/25/2000WO2000029422A1 31 human secreted proteins
05/25/2000WO2000029421A1 Selection system for generating efficient packaging cells for lentiviral vectors
05/25/2000WO2000029420A2 Methods of making modified nucleosides
05/25/2000WO2000029103A1 Method and apparatus for liposome production
05/25/2000WO2000029032A1 Methods for using heat shock proteins bound to dna or rna
05/25/2000WO2000029031A1 Nucleic acid transporters and medicinal compositions for gene therapy
05/25/2000WO2000029017A1 Mycobacterium tuberculosis superoxide dismutase
05/25/2000WO2000029012A2 Methods of alleviating cancer symptoms
05/25/2000WO2000029008A2 Hiv-specific t-cell induction
05/25/2000WO2000029004A1 Small functional units of antibody heavy chain variable regions
05/25/2000WO2000029000A1 Compositions and methods for recombinational cloning of nucleic acid molecules
05/25/2000WO2000028811A1 Animal model for neurological disorders
05/25/2000WO2000019988A8 NOVEL Th2-SPECIFIC MOLECULES AND USES THEREOF
05/25/2000WO2000018920A3 Tmof receptor and uses thereof
05/25/2000WO2000017372A3 Pineapple mealybug-associated wilt virus proteins and their uses
05/25/2000WO2000017233A3 Genes of the 1-desoxy-d-xylulose biosynthetic pathway
05/25/2000WO2000015818A3 Plant prohibitin genes and their use
05/25/2000WO2000015816A3 Maize replication protein a
05/25/2000WO2000015804A3 Method for production of peroxidases by use of a genetically modified host
05/25/2000WO2000015798A3 Mammalian transforming growth factor beta - 9 (ztgfss9)
05/25/2000WO2000015788A3 Dna sequence encoding oncofetal ferritin protein
05/25/2000WO2000015247A3 Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists
05/25/2000WO2000015209A3 REGULATION OF HER2/neu ONCONGENE EXPRESSION BY SYNTHETIC POLYAMIDES
05/25/2000WO2000014276A3 Oligo nucleotides, method and kit for detecting listeria monocytogenes by amplifying and/or hybridizing nucleic acids
05/25/2000WO2000014228A8 Neutral amino acid transporter and gene thereof
05/25/2000WO2000014227A8 Novel protein and dna thereof
05/25/2000WO2000014205A3 Methods for generating high titer helper-free preparations of released recombinant aav vectors
05/25/2000WO2000012111A3 Selective treatment of endothelial somatostatin receptors
05/25/2000WO2000009724A9 Transgenic plants expressing a mapkkk protein kinase domain
05/25/2000WO2000009543A3 Hepatitis c inhibitor tri-peptides
05/25/2000WO2000009148A9 Vascular endothelial growth factor 3
05/25/2000WO2000008924A9 Method of performing transgenesis
05/25/2000WO2000008443A9 Multiple frequency fluorescence lifetime imaging
05/25/2000WO2000008194A3 Cell lines for the propagation of mutated herpes viruses
05/25/2000WO2000008153A3 Arf-p19, a novel regulator of the mammalian cell cycle
05/25/2000WO2000007545A8 Apoptosis proteins
05/25/2000WO2000004051A3 Growth differentiation factor promoter and uses therefor
05/25/2000WO2000001801A9 Ftsz multimeric proteins and their uses
05/25/2000WO1999051762A9 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
05/25/2000WO1998049350A8 In vivo use of recombinagenic oligonucleobases to correct genetic lesions in hepatocytes
05/25/2000DE19913934C1 Production of a random primed DNA for targeted cloning, especially for qualitative gene libraries to analyze central mutations of organisms
05/25/2000DE19853726A1 Molecular biological method for solving NP problems, useful e.g. in economics, by sequential assembly of DNA fragments and examining products for one of appropriate length
05/25/2000DE19850986A1 Die gentechnische Prägung von Zellen und ihre Verwendung zur Prophylaxe und Therapie von Erkrankungen The genetic imprint of cells and their use in the prophylaxis and treatment of diseases
05/25/2000DE19850186A1 Neue Primer und Sonden zum Nachweis von HIV New primers and probes for the detection of HIV
05/25/2000DE19840263C1 Papillomviren, Mittel zu deren Nachweis sowie zur Therapie von durch sie verursachten Erkrankungen Papillomaviruses means for their detection as well as for the treatment of diseases caused by them
05/25/2000CA2803417A1 Selection system for generating efficient packaging cells for lentiviral vectors
05/25/2000CA2369119A1 Nucleotide construct with optimised codons for an hiv genetic vaccine based on a primary, early hiv isolate and synthetic envelope
05/25/2000CA2353076A1 Ligation assembly and detection of polynucleotides on solid-support
05/25/2000CA2352463A1 Methods using genetic package display for detecting and identifying protein-protein interactions
05/25/2000CA2351891A1 Analytical system based upon spore germination
05/25/2000CA2351881A1 A whole-genome radiation hybrid map of the dog genome and use thereof for identifying genes of interest
05/25/2000CA2351874A1 G protein-coupled receptor resembling the leukotriene b4 receptor
05/25/2000CA2351740A1 Method for the quantitative detection of nucleic acids
05/25/2000CA2351729A1 Cell surface receptor antigen vaccines
05/25/2000CA2351669A1 Small functional units of antibody heavy chain variable regions
05/25/2000CA2351629A1 Nucleic acid carriers and pharmaceutical compositions for gene therapy
05/25/2000CA2351622A1 Polypeptide
05/25/2000CA2351576A1 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
05/25/2000CA2351566A1 Gene coding for an acyltranferase of oil seed rape and uses thereof
05/25/2000CA2351550A1 Phosphonate metabolizing plants
05/25/2000CA2351524A1 12-25-kda bacterial proteins and their 116-58 kda polymers for use e.g. in anti-tumour vaccines
05/25/2000CA2351522A1 Egf-like nucleic acids and polypeptides and uses thereof
05/25/2000CA2351314A1 Novel recombinant adenovirus
05/25/2000CA2351313A1 Immunoglobulin superfamily proteins
05/25/2000CA2351312A1 Novel human wnt gene
05/25/2000CA2351170A1 Humanized antibody specific for human 4-1bb and pharmaceutical composition comprising same
05/25/2000CA2351022A1 Low cost manufacture of oligosaccharides
05/25/2000CA2350919A1 Antennapedia homeodomain helix 3 derived translocation vectors
05/25/2000CA2350917A1 Contraceptive antibody vaccines
05/25/2000CA2350911A1 Hiv-specific t-cell induction
05/25/2000CA2350830A1 Hypoxia-inducible factor 1.alpha. hif-1.alpha. variants and methods for identifying hif-1.alpha. modulators
05/25/2000CA2350785A1 31 human secreted proteins
05/25/2000CA2350698A1 Human glycine transporter type 2
05/25/2000CA2350623A1 Mammalian chondromodulin-like protein
05/25/2000CA2350603A1 Ring finger protein zapop3
05/25/2000CA2350415A1 Inflammation-associated genes
05/25/2000CA2350391A1 Method for inhibiting macrophage infiltration using monoclonal anti-alpha-d-antibodies
05/25/2000CA2350389A1 Calcium binding protein
05/25/2000CA2350228A1 Novel g protein-coupled receptor protein, its dna and ligand thereof
05/25/2000CA2350186A1 Promoters for gene expression in the roots of plants
05/25/2000CA2350139A1 Methods of making modified nucleosides
05/25/2000CA2350124A1 A sensitive screening system for envelope-defective recombinant virus
05/25/2000CA2350111A1 Generation of antibodies using polynucleotide vaccination in avian species
05/25/2000CA2350079A1 Udp-galactose: beta-n-acetyl-glucosamine beta1,3galactosyltransferases. beta3gal-t5
05/25/2000CA2350078A1 Method for producing antibodies acting against a polypeptide that only recognises the coding nucleic acid
05/25/2000CA2349869A1 Novel protein and utilization thereof
05/25/2000CA2349837A1 Lysozyme fusion proteins in infections
05/25/2000CA2349762A1 Human tslp dna and polypeptides
05/25/2000CA2349618A1 Compositions and methods relating to the peroxisomal proliferator activated receptor-.alpha. mediated pathway
05/25/2000CA2349588A1 Endoplasmic reticulum stress transcription factors atf6 and creb-rp